One study reported that young women with biopsy-proven NAFLD and decreased levels of SHBG have a higher likelihood of developing PCOS, further supporting the possible bidirectional relationship, as well as the potential use of SHBG as an accurate biomarker for metabolic disorders such as NAFLD and PCOS [89]. The gene discussed is SHBG; the disease is metabolic dysfunction-associated steatotic liver disease.